PALATIN TECHNOLOGIES, INC. Increase (Decrease) in Other Operating Liabilities
PALATIN TECHNOLOGIES, INC. (PTN) reported Increase (Decrease) in Other Operating Liabilities of -$2.04 million for the 12-month period ending 2023-06-30, per its 10-K filed 2023-09-28.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherOperatingLiabilities · last filed 2023-09-28
- PALATIN TECHNOLOGIES, INC. increase (decrease) in other operating liabilities for the quarter ending 2023-06-30 was -$1.03M.
- PALATIN TECHNOLOGIES, INC. increase (decrease) in other operating liabilities for the quarter ending 2022-06-30 was $0.00, a 100.00% decline year-over-year.
- PALATIN TECHNOLOGIES, INC. increase (decrease) in other operating liabilities for the quarter ending 2021-06-30 was $24.42K.
- PALATIN TECHNOLOGIES, INC. increase (decrease) in other operating liabilities for the quarter ending 2020-03-31 was $0.00, a 100.00% decline year-over-year.
- PALATIN TECHNOLOGIES, INC. increase (decrease) in other operating liabilities for fiscal 2023 was -$2.04M.
- PALATIN TECHNOLOGIES, INC. increase (decrease) in other operating liabilities for fiscal 2022 was -$1.00M.
- PALATIN TECHNOLOGIES, INC. increase (decrease) in other operating liabilities for fiscal 2021 was -$7.56M.
| Period end | Increase (Decrease) in Other Operating Liabilities 3 month | Increase (Decrease) in Other Operating Liabilities 6 month | Increase (Decrease) in Other Operating Liabilities 9 month | Increase (Decrease) in Other Operating Liabilities 12 month |
|---|---|---|---|---|
| 2023-06-30 | -$1.03M derived: 10-K 12 month − 10-Q 9 month · filed 2023-09-28 | -$2.04M 10-K · filed 2023-09-28 | ||
| 2023-03-31 | -$1.01M 10-Q · filed 2023-05-15 | |||
| 2022-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-09-28 | -$1.00M 10-K · filed 2023-09-28 | ||
| 2022-03-31 | -$1.00M 10-Q · filed 2023-05-15 | |||
| 2021-06-30 | $24.42K derived: 10-K 12 month − 10-Q 9 month · filed 2022-09-22 | -$7.56M 10-K · filed 2022-09-22 | ||
| 2021-03-31 | -$7.58M 10-Q · filed 2022-05-16 | |||
| 2020-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-05-11 | $0.00 10-Q · filed 2020-05-11 | ||
| 2019-12-31 | $0.00 10-Q · filed 2020-02-10 | |||
| 2019-03-31 | $8.70K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-05-11 | $51.64K 10-Q · filed 2020-05-11 | ||
| 2018-12-31 | $42.95K 10-Q · filed 2020-02-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B |